Exscientia Focus Firmly On Pipeline After CEO Exit Scandal

The sacking of CEO Andrew Hopkins over inappropriate relationships with two employees has cast a cloud over the high-profile AI biotech.

Andrew Hopkins
Andrew Hopkins • Source: Exscientia

The lights have dimmed at one of the brightest stars in UK biotech as the artificial intelligence specialist Exscientia plc faces up to the fallout from the sacking of founder and CEO Andrew Hopkins over “inappropriate” relationships with two members of staff.

Shares in the NASDAQ-listed Oxford-based group slumped nearly 23% to $5.80 on 13 February after Exscientia revealed in a US...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Executives On The Move

More from Leadership